O'Shaughnessy Asset Management, LLC Trevi Therapeutics, Inc. Transaction History
O'Shaughnessy Asset Management, LLC
- $14.2 Billion
- Q2 2025
A detailed history of O'Shaughnessy Asset Management, LLC transactions in Trevi Therapeutics, Inc. stock. As of the latest transaction made, O'Shaughnessy Asset Management, LLC holds 12,644 shares of TRVI stock, worth $121,129. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,644Holding current value
$121,129% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding TRVI
# of Institutions
163Shares Held
109MCall Options Held
1.08MPut Options Held
425K-
Nea Management Company, LLC Timonium, MD13.2MShares$127 Million6.0% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA10.3MShares$98.3 Million2.96% of portfolio
-
Rubric Capital Management LP New York, NY8.53MShares$81.7 Million1.08% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.32MShares$50.9 Million0.0% of portfolio
-
Vivo Capital, LLC Palo Alto, CA4.49MShares$43 Million5.2% of portfolio
About Trevi Therapeutics, Inc.
- Ticker TRVI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 58,322,500
- Market Cap $559M
- Description
- Trevi Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of Haduvio to treat serious neurologically mediated conditions. The company is developing Haduvio, an oral extended-release formulation of nalbuphine, which is in phase IIb/III clinical trial for the treatment of chronic pruritu...